Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF-Reference-Cited by-同舟云学术

Nitric oxide metabolites: associations with cardiovascular biomarkers and clinical parameters in patients with HFpEF

Published:2022-08-18 Issue:6 Volume:9 Page:3961-3972
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Piatek Karsten¹^ORCID,Feuerstein Anna¹²,Zach Veronika¹,Rozados da Conceicao Cristina¹,Beblo Amelie¹,Belyavskiy Evgeny¹,Pieske‐Kraigher Elisabeth¹,Krannich Alexander³,Schwedhelm Edzard⁴⁵,Hinz Sarah⁴,Pieske Burkert¹²⁶,Edelmann Frank¹²

Affiliation:

1. Department of Internal Medicine and Cardiology Charité – Universitätsmedizin Berlin, Campus Virchow Klinikum Augustenburger Platz 1 Berlin 13353 Germany

2. DZHK (German Centre for Cardiovascular Research), Partner Site Berlin Berlin Germany

3. Experimental and Clinical Research Center (ECRC) Charité – Universitätsmedizin Berlin Berlin Germany

4. Institute of Clinical Pharmacology and Toxicology University Medical Center Hamburg‐Eppendorf Hamburg Germany

5. DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck Hamburg Germany

6. Department of Cardiology Deutsches Herzzentrum Berlin (DHZB) Berlin Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.14116

Reference47 articles.

1. Trends in Patients Hospitalized With Heart Failure and Preserved Left Ventricular Ejection Fraction

2. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

3. A Novel Paradigm for Heart Failure With Preserved Ejection Fraction

4. Regulation of biosynthesis of nitric oxide.

5. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endothelial dysfunction: molecular mechanisms and clinical implications;MedComm;2024-07-22

2. Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure;International Journal of Molecular Sciences;2024-02-20

3. Plasma Metabolic Profiling Analysis of Heart Failure with Preserved Ejection Fraction Patients Based on UHPLC-MS/MS;2024-01-23

4. An altered plasma lipidome–phenome network characterizes heart failure with preserved ejection fraction;ESC Heart Failure;2024-01-19

5. The two different profiles in heart failure with preserved ejection fraction and type 2 diabetes mellitus: ischemic and diabetic;Current Medical Research and Opinion;2024-01-19